PV Bulletin

Search Pharmacovigilance & Regulatory Intelligence

Search published pharmacovigilance and regulatory intelligence briefings by regulator, product, workflow, QPPV topic, or safety signal.

Found 91 result(s) for "European Medicines Agency".

Showing 81-91 of 91 published article match(es)

publicEuropean Medicines Agency · European Union · Updated Sep 24, 2026

New National Coordination Requirement for QR Code Implementation of Veterinary Medicinal Products

Awareness · Medium

PV teams must update workflows and SOPs to include the requirement of contacting member state contact points prior to the launch of QR code content, specifically when it contains non-statutory information.

Country ComplianceRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicEuropean Medicines Agency (EMA) · European Union · Updated Sep 18, 2026

New Scientific Guideline for User Safety Risk Assessments in Veterinary Medicinal Products

Awareness · Medium

PV teams need to update SOPs and workflows related to user safety risk assessments and ensure that procedures are aligned with the new draft guidelines prior to its implementation following the consultation.

Signal ManagementCountry ComplianceRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicEuropean Medicines Agency · European Union · Updated Sep 18, 2026

New Consultation Period for Veterinary Pharmacovigilance Signal Management Guidelines

Awareness · Medium

PV teams must engage in the public consultation by preparing comments on the draft guideline. Additionally, update any related SOPs and compliance controls to align with the new structured signal management framework once finalized.

Signal ManagementQPPV
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: QPPV, Signal Management Lead, PV Quality Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicEuropean Medicines Agency · European Union · Updated Sep 18, 2026

New Pharmacovigilance Recommendations for Veterinary Medicinal Products in 2026

Awareness · Medium

PV teams must ensure that their workflows, SOPs, and compliance controls are updated to reflect the new pharmacovigilance recommendations issued by the EMA for 2026. Attention should be given to the monthly updates for product-specific implications.

Signal ManagementQPPV
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: QPPV, Signal Management Lead, PV Quality Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicEuropean Medicines Agency · European Union · Updated Sep 17, 2026

Updated Timeline for Plasma Master File Submissions: Period 2026-2028

Awareness · Medium

PV teams must review and update their workflows related to regulatory intelligence monitoring to align with the new PMF submission timelines and ensure compliance with upcoming guidelines specified in the 3-year work plan.

Country ComplianceRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicEuropean Medicines Agency (EMA) · European Union · Updated Sep 17, 2026

New 60-Day Timetable for Plasma Master File Submissions (2026-2028)

Awareness · Medium

Update workflows and SOPs related to Country Compliance and PMF submission processes to ensure timely response to the newly defined 60-day timelines.

Country ComplianceRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicEuropean Medicines Agency · European Union · Updated Sep 16, 2026

Updated Guidance on QT/QTc Interval Prolongation Evaluation for Non-Antiarrhythmic Drugs

Awareness · Medium

PV teams should update their Standard Operating Procedures (SOPs) related to QT/QTc evaluation methods, integrate new assessment frameworks based on the revised guidelines, and consider the necessity for training on these updates.

Signal ManagementLabelingRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicEuropean Medicines Agency · European Union · Updated Sep 14, 2026

New Requirements for Periodic Safety Update Reports in the EU

Awareness · Medium

PV teams must update their workflows and SOPs to align with the new PSUR requirements, increasing the frequency and detail of safety monitoring and adverse event reporting. Staff training may be necessary to ensure compliance with these changes.

Signal ManagementCountry ComplianceRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, PV Quality Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicEuropean Medicines Agency · European Union · Updated Sep 14, 2026

New Insights on International Active Pharmaceutical Ingredient Inspections Impacting Regulatory Practices

Awareness · Medium

PV teams should update workflows related to Inspection Readiness and adjust compliance controls to emphasize reliance on inter-authority inspections as part of their preparation strategies.

Inspection ReadinessRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, PV Quality Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicEuropean Medicines Agency (EMA) · European Union · Updated Sep 14, 2026

Enhanced International Collaboration on GMP Inspections

Awareness · Medium

PV teams must revise SOPs for inspection readiness to incorporate increased collaboration and risk-based planning protocols, ensuring that workflows align with the new inspection resource allocation strategies.

Inspection ReadinessRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, PV Quality Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicEuropean Medicines Agency · European Union · Updated Sep 14, 2026

New Requirements for Periodic Safety Update Report Single Assessments in the EU

Awareness · Medium

PV teams must update their SOPs to incorporate new timelines and reporting requirements related to PSUSAs. Ensure workflows related to regulatory intelligence and signal management are aligned with the new EMA guidelines to maintain compliance.

Signal ManagementRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward

Page 5 of 5

Get updates for your PV role

Subscribe to impact-first pharmacovigilance updates. Select every role you want in your digest.

Digest roles: QPPV. Work email only